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In the last decade asymmetric transfer hydrogenation (ATH) has been revealed as a valid alternative to the use of molecular H 2 in obtaining enantiomerically pure alcohols which can be applied to the synthesis of many fine chemicals, pharmaceuticals and agrochemical products 1 . 25 It is well known that the performance of the catalytic system is strictly related to a synergic effect between the solvent nature and the hydrogen donor. In the recent years the development of ATH in aqueous media has been emerged as a valid alternative to the use of organic solvents for its non toxic, economic and 30 environmental compatible profile. Since the pioneering work by Noyori and Ikariya groups in 1995 2, 3 , the catalysts of choice in ATH reductions of ketones have been established to be the ruthenium(II) complexes chelating different substituted 1,2-diamines such as DPEN and its derivatives, 35 among them the monotosylated compounds were revealed as the most efficient ones [3] [4] [5] [6] [7] [8] [9] [10] [11] . All these types of catalysts were based on the presence of ligands forming five membered rings when chelated to the metal centre. Some examples of symmetric 1,4 diamines and few examples of 40 1,3-diamines were reported in literature, [12] [13] [14] [15] [16] [17] mainly used as a typical ruthenium complex [(diphosphine)-RuCl 2 -(diamine)] for hydrogenation of simple aromatic and aliphatic ketones, in catalytic addition of diethylzinc to aldehyde or in Cu-catalyzed enantioselective Henry reaction. 18-21 45 Considering the wide range of 1,2-diamines used as ligands and their utility in asymmetric catalysis, this work reported the synthesis of simple asymmetric monotosylated 1,3-diamines, up to now poorly investigated in ATH ( Figure 1 ) and the evaluation of their catalytic performances. 
Results and Discussion
The starting material for the synthesis of these 1,3-diamines was the reduction products of benzoylacetonitrile and its ethylated 55 derivative. Different approaches using either asymmetric transfer hydrogenation for the reduction of benzoylacetonitrile 5 with iridium(III) 22 and/or ruthenium(II) diamines complexes 23 or whole-cell catalysts 24, 25 were studied. Recently our group 60 displayed the reduction of the substrate 5 and its corresponding ethylated derivative 5b using Carreira's [Cp*Ir(diamine)(H 2 O)]SO 4 complexes in which the diamine ligand CAMPY and its derivatives were used as source of chirality 26 with good stereoselectivity. Unfortunately it was not enough to use these products as starting materials for the synthesis of enantiomerically pure diamines. Good results were obtained by a biotransformation reaction which has been studied especially by Gotor and Dehli [27] [28] [29] employing the fungus Curvularia lunata. In these works they underlined the production 5 of the expected side product, 2-(1-hydroxy-1-phenylmethyl)butanenitrile 5c, during the biotransformation occurring on benzoylacetonitrile 5. Figure 2 . Biotransformation of benzoylacetonitrile by yeasts. 10 On the basis of the above results we decided to investigate different yeasts able to reduce the same substrate 5 and its derivative 5b. A screening of different genera and species of yeasts available in our laboratory's library was carried out (data not reported). (Figure 2 ) 15 Most of them resulted to produce the ethylated keto-compound 5b as the major product while the 3-hydroxy-3-phenylpropanenitrile 5 was produced in a minor amount in the presence of glucose as co-substrate. The group of red to pinkish yeasts is one of the most interesting biocatalysts [30] [31] [32] [33] in the reduction of differently substituted arylketones and among them Sporobolomyces salmonicolor is the best known for this application. As expected, this yeast was able 25 to produce the desired product 5a in a quantitative yield with 80% e.e. in S configuration avoiding the use of any co-substrate. In the presence of EtOH as co-substrate this yeast afforded 5a and 5c in a 50/50 mixture along with a decreasing enantiomeric excess. Best results were obtained when two similar yeasts were 30 used: Rhodotorula rubra MIM 146 and Rhodotorula rubra MIM 147. In both cases 5a was the only product yielded in an excellent 98% e.e. in S configuration. With the aim to verify the ability of these two yeasts to reduce and resolve compound 5b, its racemic mixture was quantitatively synthesised by Saccharomyces 35 cerevisiae which mediated non-stereoselective introduction of the ethyl group. 34, 35 With R. rubra MIM 146 the conversion of racemic 5b in 5c was achieved in 48 h with 78% d.e. and >99% e.e. in S,S configuration. The best result was obtained with R. rubra MIM 147 which produced S,S-5c at the same time with 40 >99% e.e. and with a d.e. up to 90% thus allowing to completely separate the two diastereomers by classical chromatographic techniques. First of all, starting from linear substrate S-5a, two different types of diamines were synthesised in which the tosyl-amine moiety 45 was set either on aliphatic chain or on the preformed stereocentre. (Scheme 1) After obtaining the corresponding aminoalcohol 6a by reduction with LiAlH 4 , the synthesis proceeded into two different pathways. The cyclisation with CDI in CH 2 Cl 2 gave the 50 corresponding (S)-6-phenyl-1,3-oxazinan-2-one 7a with retention of configuration. 36 Successively, the reaction with NaH and TsCl provided 6-phenyl-3-tosyl-1,3-oxazinan-2-one 10a, with an excellent yield (80% after crystallization). In the second pathway, after protecting the amino group with (Boc) 2 O, substrate 8a reacts 55 with TsCl in presence of 4-DMAP and TEA directly giving 10a with the inversion of configuration at the chiral centre.
Indeed, under these specific conditions, the formation of TsO-on 60 the benzylic alcohol and the tosylation of the amido moiety allowed by the 4-DMAP, drove a SN 2 reaction. This methodology appears very appealing considering that starting from only one isomer we obtained both the enantiomers of 10a. (Scheme 1) (trimethylsilyl)ethoxycarbonyloxy]pyrrolidin-2,5-dione (TeocOSu). Then the classic procedure, by which the alcoholic function was reacted with mesyl chloride in presence of TEA, 16 was performed unfortunately giving the corresponding oxazinanone R-7a, with inversion of configuration, as observed 5 when Boc is used as protecting group for the amino moiety. Therefore, an alternative starting material, (R)-(+)-3-chloro-1-phenyl-1-propanol, for the synthesis of enantiopure diamine S-2 was studied. The synthesis proceeded as reported in the following scheme. (Scheme 2) 10 Scheme 2. Synthesis of linear diamines 2.
The second type of diamines was synthesised starting from the reduced ethylated product 5c. The synthesis of diamine 3 vs 1 15 mirrored each other from the beginning to the end. (Scheme 3) In the case of diamine 4, the methodology was the same of that 20 initially thought for diamine 2 but in this case the formation of oxazinanone 7c didn't take place and after removing the Teoc protecting group with ZnBr 2 , 37 diamines 1 and 2 were studied in ATH of different aryl ketones. (Table 2) The best results both in terms of reaction rate and enantioselectivity were achieved with the catalyst bearing diamine ligand R-1 if compared to catalyst carrying S-2 diamine 5 (entries 1-9 vs 10-18). In particular in the reduction of α-tetralone, an appreciable 63 % e.e. was achieved with a yield of 70 % in 48 h (entry 9). a Reactions were carried out at 40°C using 0.5 mmol of substrate with 0.5 mol % of ruthenium complex in 3 mL of water in presence of 10 equiv. HCOONa as hydrogen donor.
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b Conversion was determined by NMR and e.e. was determined by HPLC after 48 h.
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Conclusions
Easily prepared 1,3-diamines were developed starting from chiral substrates. The production of the starting material was realised by a biocatalytic approach using a non-conventional yeast, Rhodotorula rubra MIM 147, achieving very good results in 25 terms of stereoselectivity, yield and recovery. The catalytic data showed that when a six membered ring was formed by employing 1,3 diamines as source of chirality, enlarged if compared to the one obtained by using 1,2 ligands, a lower optical induction was observed due to the flexibility of the 30 chelating ring as already underlined for the diphosphine ligands. 43 Nevertheless the right combination between the hydrogen donor and the solvent proved to drastically influence the catalytic performance of this type of catalysts as well as the electronic and steric properties of the substrate.
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Experimental Section
General. 1 H and 13 C NMR spectra were recorded in CDCl 3 or CD 3 OD on Bruker DRX Avance 300 MHz equipped with a nonreverse probe at 25°C. Chemical shifts (in ppm) were referenced to residual solvent proton/carbon peak. FTIR spectra were 40 collected by using a Perkin Elmer (MA, USA) FTIR Spectrometer "Spectrum One" in a spectral region between 4000 and 450 cm -1 and analysed by transmittance technique with 32 scansions and 4 cm -1 resolution. Polarimetry analyses were carried out on Perkin Elmer 343 Plus equipped with Na/Hal lamp. The biotransformation system was shaken with mechanic stirrer at 28°C. When the total conversion was achieved, the cells were separated by centrifugation. Both the aqueous phases and the cells mixture were extracted with diethyl ether (3x50 mL), dried with Na 2 SO 4 and the solvent was removed in vacuo. The crude product was purified by flash chromatography (CH 2 Cl 2 /hexane/ethyl acetate = 4:1:1) to give 860 mg of 5b (86% yield). 1 , agar 15 g L −1 , pH 5.6). The strain, grown on malt extract slants for 72 h at 28 °C, 85 was inoculated into 1000 mL Erlenmeyer flasks containing 150 mL of the same liquid medium and incubated on a reciprocal shaker (100 spm) for 48 h at 28°C. Cells obtained by
centrifugation (4000×g for 15 min at 4°C) of the culture broth (1 L) were washed with deionised water (3x200 mL). After lyophilisation 20 g/L of yeast was suspended in 500 mL of 0.1M phosphate buffer pH = 7 containing 50 g L -1 of glucose. The substrates dissolved in DMSO were added to the 5 biotransformation system in 2 g L -1 (5) or 1 g L -1 (rac-5b) of substrate concentration and 1% of solvent. The biotransformation system was shaken with mechanic stirrer at 28°C for 48 h. The cells were separated by centrifugation and both were extracted with diethyl ether (3x150 mL), dried with Na 2 SO 4 and the solvent 10 was removed in vacuo. The crude product was purified by flash chromatography (ethyl acetate/cyclohexane = 7:3) to give 786 mg of S-5a (78% yield) or 287 mg of S,S-5c (57% yield). S-5a: All characterization data are in agreement with previously reported literature. 22 ).
General synthesis of tosyl-oxazinanones S-10a or S,S-9c:
To a solution of S-7a or S,S-7c (1.69 mmol) in anhydrous THF at 0°C the stoichiometric amount of NaH was added (68 mg, 1.69 90 mmol). After thirty minutes the solution of tosyl chloride in THF (387 mg, 2.03 mmol) was dropped into the former solution and stirred at room temperature overnight. The resulting solution was quenched with water and extracted with trichloromethane (3x10 mL). The collected organic layers were dried on Na 2 SO 4 , filtered 95 and evaporated to give a yellow oil then purified by crystallization in dichloromethane/hexane to provide the product. (S)-6-phenyl-3-tosyl-1,3-oxazinan-2 
Synthesis of (R)-6-phenyl-3-tosyl-1,3-oxazinan-2-one R-10a:
To a solution of 8a (270 mg, 1.08 mmol) in fresh-distilled dichloromethane, 4-dimethylaminopyridine (99 mg, 0.81 mmol) and triethylamine (2 mL, 14.04 mmol) were added. The reaction mixture was then cooled to -10°C and stirred for half an hour. A 10 solution of tosyl chloride (267 mg, 1.4 mmol) in dichloromethane was then dropped into the former solution and stirred overnight allowing the reaction mixture to reach room temperature. The reaction was monitored by TLC using dichloromethane/diethyl ether 1:1 as eluent. After 24 h the reaction is completed. The N-(3-amino-3-phenylpropyl) N-(3-amino-3-phenylpropyl) mixture of THF/water 1:1, Na 2 CO 3 was added (720 mg, 6.76 mmol). The solution was then cooled to 0°C and a solution of ditert-butyl dicarbonate (770 mg, 3.53 mmol) in 5 mL THF was added dropwise. After 1 h stirring at 0°C, the solution was warmed to room temperature and stirred for further 3 h. The 95 reaction was monitored by TLC using dichloromethane/diethyl ether 1:1 as eluent. After 4 h the reaction was complete and water was added to the mixture and extracted with diethyl ether (3x10 mL) to give the product as a yellow oil (575 mg, 78% yield). 
General synthesis of Teoc-amino alcohols S-9a or S,S-8c:
The synthesis proceeded according to methodology reported in literature. 24 (m, 2H, -CH 2 -) ). N-(3-azido-1-phenylpropyl)-4 -methylbenzen sulfonamide S-14a: Compound 13a (40 mg, 0.124 mmol) was 10 dissolved in dry DMSO (5 mL) and NaN 3 (80 mg, 1.24 mmol) was added. After 24 h at 100°C, the solution was cooled to room temperature, water (2 mL) was added and the mixture was extracted with diethyl ether (3x5 mL). The collected organic layers were washed with an aqueous solution of NaHCO 3 , dried 15 on Na 2 SO 4 , filtered and evaporated to give the product S-14a as a white solid (40 mg, 97% yield ).
Synthesis of (S)-
Synthesis of (S)-N-(3-amino-1-phenylpropyl)-4-methylbenzen sulfonamide S-2:
In a stainless steel autoclave (20 mL), equipped with temperature control and a magnetic stirrer, purged 30 five times with hydrogen, a solution of 14a (40 mg, 0.121 mmol) in methanol with 1% of Pd/C was transferred. The autoclave was pressurised at 20 atm and kept under stirring at room temperature for four hours. The mixture was then filtered on Celite and the solvent was evaporated in vacuo to give the product S-2 as a 35 yellow pale oil (35 mg, 95% yield 
Synthesis of N-((1R,2S)-2-(aminomethyl)-1-phenylbutyl)-4-
45
methylbenzenesulfonamide R,S-4: The synthesis proceeded as reported in literature. 37 The product was recovered as colourless oil (58 mg, 87% yield). [α] 
